SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-203691
Filing Date
2024-08-20
Accepted
2024-08-20 16:31:30
Documents
16

Document Format Files

Seq Description Document Type Size
1 424B5 d875859d424b5.htm 424B5 503698
2 EX-FILING FEES d875859dexfilingfees.htm   iXBRL EX-FILING FEES 47895
3 GRAPHIC g875859g00a48.jpg GRAPHIC 30432
4 GRAPHIC g875859g00a91.jpg GRAPHIC 26161
5 GRAPHIC g875859g94j64.jpg GRAPHIC 35104
  Complete submission text file 0001193125-24-203691.txt   821399

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT d875859dexfilingfees_htm.xml XML 11178
Mailing Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472
Business Address 500 NORTH BEACON STREET, 4TH FLOOR WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-259955 | Film No.: 241225636
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)